Tools
ToolsHall, Alistair S, Jackson, Beryl M, Farrin, Amanda J, Efthymiou, Maria, Barth, Julian H, Copeland, Joanne, Bailey, Kristian M, Romaine, Simon P R, Balmforth, Anthony J, McCormack, Terry, Whitehead, Andrew, Flather, Marcus D and Nixon, Jane and SPACE ROCKET Trial Group (2009) A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction:the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial. European Journal of Cardiovascular Prevention and Rehabilitation, 16 (6). pp. 712-21. ISSN 1741-8275
Full text not available from this repository. (Request a copy)Abstract
We sought to evaluate reports that rosuvastatin 10 mg is a more efficacious treatment of hyperlipidaemia than is simvastatin 40 mg, hoping to assess this issue in the previously unstudied context of acute myocardial infarction.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | aged,biological markers,cholesterol,cholesterol, ldl,female,fluorobenzenes,great britain,humans,hydroxymethylglutaryl-coa reductase inhibitors,hyperlipidemias,male,middle aged,myocardial infarction,odds ratio,practice guidelines as topic,prospective studies,pyrimidines,recurrence,secondary prevention,simvastatin,sulfonamides,time factors,treatment outcome |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023) |
| Depositing User: | Pure Connector |
| Date Deposited: | 06 Jan 2014 14:58 |
| Last Modified: | 03 Nov 2022 15:35 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/46258 |
| DOI: | 10.1097/HJR.0b013e3283316ce8 |
Actions (login required)
 |
View Item |